Cargando…

Efficacy and Safety of Remimazolam for Procedural Sedation: A Meta-Analysis of Randomized Controlled Trials With Trial Sequential Analysis

Background: Remimazolam is a new ultrashort-acting benzodiazepine. Remimazolam has been approved for procedural sedation by the US Food and Drug Administration in 2020. However, prior trials and the participants they enrolled were limited. Aim: In this meta-analysis, we investigated the effectivenes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jhuang, Bo-Jyun, Yeh, Bo-Han, Huang, Yen-Ta, Lai, Pei-Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353129/ https://www.ncbi.nlm.nih.gov/pubmed/34386505 http://dx.doi.org/10.3389/fmed.2021.641866

Ejemplares similares

Remimazolam versus propofol for procedural sedation: a meta-analysis of randomized controlled trials
por: Chang, Yu, et al.
Publicado: (2023)

Efficacy and Safety of Remimazolam in Endoscopic Sedation—A Systematic Review and Meta-Analysis
por: Zhu, Xianlin, et al.
Publicado: (2021)

Efficacy and safety of remimazolam in procedural sedation and analgesia: A protocol for systematic review and meta analysis
por: Wang, Feng, et al.
Publicado: (2020)

Efficacy and Safety Profile of Remimazolam for Sedation in Adults Undergoing Short Surgical Procedures
por: Morimoto, Yasuhiro
Publicado: (2022)

The Availability and Safety Study of Remimazolam Besylate for Injection on Sedation of ERAS Patients Under Mechanical Ventilation in ICU: Protocol for a Randomized, Open-Label, Controlled Trial
por: Liu, Shengjun, et al.
Publicado: (2021)

Remimazolam for Pediatric Procedural Sedation: Results of an Institutional Pilot Program
por: Hirano, Tatsuya, et al.
Publicado: (2023)

Intravenous Infusion of Lidocaine for Bowel Function Recovery After Major Colorectal Surgery: A Critical Appraisal Through Updated Meta-Analysis, Trial Sequential Analysis, Certainty of Evidence, and Meta-Regression
por: Chen, Po-Chuan, et al.
Publicado: (2022)

The effective doses of remimazolam besylate in the procedural sedation of endoscopic retrograde cholangiopancreatography
por: Tan, Dan‐Dan, et al.
Publicado: (2022)

Moderate sedation by total intravenous remimazolam-alfentanil vs. propofol-alfentanil for third molar extraction: A prospective randomized controlled trial
por: Zhao, Nan, et al.
Publicado: (2022)

Efficacy of remimazolam versus midazolam for procedural sedation: post hoc integrated analyses of three phase 3 clinical trials
por: Dao, Van-Anh, et al.
Publicado: (2022)

Efficacy and Safety of Remimazolam Tosilate Combined With Esketamine for Analgesic Sedation in Mechanically Ventilated ICU Patients: A Single-Arm Clinical Study Protocol
por: Song, Xuan, et al.
Publicado: (2022)

Comparison of oxygen reserve index according to the remimazolam or dexmedetomidine for intraoperative sedation under regional anesthesia—A single-blind randomized controlled trial
por: Lee, Sangho, et al.
Publicado: (2023)

Safety and efficacy of remimazolam for general anesthesia in elderly patients undergoing laparoscopic cholecystectomy: a randomized controlled trial
por: So, Keum Young, et al.
Publicado: (2023)

Population Pharmacokinetics of Remimazolam in Procedural Sedation With Nonhomogeneously Mixed Arterial and Venous Concentrations
por: Zhou, Jie, et al.
Publicado: (2020)

Remimazolam: The future of its sedative potential
por: Goudra, Basavana Gouda, et al.
Publicado: (2014)

Service Evaluation of the Impact of Capnography on the Safety of Procedural Sedation
por: Corbett, Gareth, et al.
Publicado: (2022)

Efficacy and safety of remimazolam tosylate for sedation during upper gastrointestinal endoscopy: study protocol for a multicenter randomized controlled trial
por: Zhu, Huichen, et al.
Publicado: (2022)

Review of remimazolam and sedatives in the intensive care unit
por: Choi, Hey-Ran, et al.
Publicado: (2022)

Remimazolam for Sedation During Fiberoptic Intubation in an Adolescent
por: Hughes, Mitchell, et al.
Publicado: (2023)

Remimazolam Tosylate Combined with Low-Dose Propofol Improves Sedation and Safety in Hysteroscopy
por: Zhang, Fan, et al.
Publicado: (2022)

Corrigendum: Service evaluation of the impact of capnography on the safety of procedural sedation
por: Corbett, Gareth, et al.
Publicado: (2022)

Safety and Efficacy of Roxadustat for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis and Trial Sequential Analysis
por: Liu, Chao, et al.
Publicado: (2021)

Effectiveness and Adverse Events of Gabapentinoids as Analgesics for Patients with Burn Injuries: A Systematic Review with Meta-Analysis and Trial Sequential Analysis
por: Chiang, Liang-Jui, et al.
Publicado: (2023)

The comparison of remimazolam and midazolam for the sedation of gastrointestinal endoscopy: a meta-analysis of randomized controlled studies
por: Zhang, Lin, et al.
Publicado: (2022)

Remimazolam: An Updated Review of a New Sedative and Anaesthetic
por: Hu, Qinxue, et al.
Publicado: (2022)

Remimazolam for Sedation During Upper Gastrointestinal Endoscopy in an Adolescent
por: Garrett, Alexandrea, et al.
Publicado: (2022)

A population pharmacodynamic Markov mixed‐effects model for determining remimazolam‐induced sedation when co‐administered with fentanyl in procedural sedation
por: Zhou, Jie, et al.
Publicado: (2021)

Efficacy and safety of dorzagliatin for type 2 diabetes mellitus: A meta-analysis and trial sequential analysis
por: Yu, Yunfeng, et al.
Publicado: (2022)

Sedative effect of remimazolam combined with alfentanil in colonoscopic polypectomy: a prospective, randomized, controlled clinical trial
por: Xin, Yueyang, et al.
Publicado: (2022)

Efficacy of Remimazolam for Procedural Sedation in American Society of Anesthesiologists (ASA) I to IV Patients Undergoing Colonoscopy: A Systematic Review and Meta-Analysis
por: Ul-Haque, Ibtehaj, et al.
Publicado: (2022)

Evaluation of efficacy and safety of propofol in the treatment of procedural sedation/anesthesia in neonates: A protocol for systematic review and meta-analysis
por: Yu, Pei-Xia, et al.
Publicado: (2021)

The hemodynamic stability of remimazolam compared with propofol in patients undergoing endoscopic submucosal dissection: A randomized trial
por: Qiu, Yuwei, et al.
Publicado: (2022)

Remimazolam tosylate's long-term sedative properties in ICU patients on mechanical ventilation: effectiveness and safety
por: Yao, Zhiyuan, et al.
Publicado: (2023)

The Efficacy and Safety of Early Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials
por: Xiao, Chuan, et al.
Publicado: (2022)

Efficacy and Safety of Remimazolam Besylate versus Dexmedetomidine for Sedation in Non-Intubated Older Patients with Agitated Delirium After Orthopedic Surgery: A Randomized Controlled Trial
por: Deng, Yang, et al.
Publicado: (2022)

Efficacy and safety of remimazolam for procedural sedation during ultrasound-guided transversus abdominis plane block and rectus sheath block in patients undergoing abdominal tumor surgery: a single-center randomized controlled trial
por: Xiao, Yimin, et al.
Publicado: (2022)

Efficacy and safety of remimazolam besilate for sedation in outpatients undergoing impacted third molar extraction: a prospective exploratory study
por: Oue, Kana, et al.
Publicado: (2023)

Comparative analysis of the effect of electromyogram to bispectral index and 95% spectral edge frequency under remimazolam and propofol anesthesia: a prospective, randomized, controlled clinical trial
por: Xin, Yueyang, et al.
Publicado: (2023)

Correction: Efficacy and safety of remimazolam for procedural sedation during ultrasound-guided transversus abdominis plane block and rectus sheath block in patients undergoing abdominal tumor surgery: a single-center randomized controlled trial
por: Xiao, Yimin, et al.
Publicado: (2023)

Remimazolam Compared to Propofol During Hysteroscopy: A Safety and Efficacy Analysis
por: Fan, Shunyi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4hq1hep406ppa64cfj6mthgb5u